Benzodiazepines and medications acting on benzodiazepine receptors that do not have a
benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory …

Catatonia is a psychomotor syndrome associated with several psychiatric and medical
conditions. Psychomotor signs range from stupor to agitation, and include pathognomonic …

Introduction Neuropsychiatric manifestations of the coronavirus disease 2019 (COVID-19)
have been described, including anosmia, ageusia, headache, paresthesia, encephalitis and …

The British Association for Psychopharmacology developed an evidence-based consensus
guideline on the management of catatonia. A group of international experts from a wide …

Background The pandemic of coronavirus disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as one of the biggest …

Catatonia is a serious, common syndrome of motoric and behavioral dysfunction, which
carries high morbidity and mortality. Electroconvulsive therapy (ECT) is the definitive …

Introduction: Individuals with profound autism often present for inpatient care due to
aggression. Diagnostic and treatment options are limited. Agitated catatonia is a treatable …

Catatonia is a neuropsychiatric disorder characterised by altered movement, speech, and
behaviour. Clozapine is an established therapy for treatment-resistant schizophrenia, but its …

Catatonia occurs secondary to both primary psychiatric and neuromedical etiologies.
Emerging evidence suggests possible linkages between causes of catatonia and …

Objective The goal is to expand our knowledge of catatonia occurring in adolescents and
young adults with Down syndrome (DS) by describing the first prospective, consecutive, well …